Recent trials of antioxidant therapy: What should we be telling our patients?

Cleveland Clinic Journal of Medicine

Volumn 71, Issue 4, 2004, Pages 327-334

  Hasnain, Bibi I ^a   Mooradian, Arshag D ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MOLYBDENUM; NICOTINIC ACID; OMEGA 3 FATTY ACID; RETINOL; RIBOFLAVIN; SELENIUM; SIMVASTATIN; ZINC;

ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIARRHEA; DISEASE EXACERBATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOXICITY; DRUG USE; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART PROTECTION; HEMOLYSIS; HUMAN; LOW DRUG DOSE; LUNG CANCER; OSTEOPOROSIS; OXIDATIVE STRESS; PATIENT COUNSELING; RETINITIS PIGMENTOSA; REVIEW; RISK BENEFIT ANALYSIS; TERATOGENICITY;

EID: 4444333965     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.4.327     Document Type: Review

References (31)

1. Smith EL, Hill RL, Lehman IR, Lefkowitz RJ, Handler P, White A. Introduction to Metabolism: Principles of Bioenergetics. Principles of Biochemistry: General Aspects. 7th ed. New York: McGraw-Hill, 1983; 247.
2. Young IS, Woodside JV. Antioxidants in health and disease. Clin Pathol 2001; 54:176-186.
3. Halliwell B, Gutteridge JC. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995; 18:125-126.
4. Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine. 2nd ed. Oxford: Clarendon Press, 1989.
5. Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly. The Rotterdam Study. Am J Clin Nutr 1999; 69:261-266.
6. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary in post-menopausal women. N Engl J Med 1996; 334:1156-1162.
7. Losonczy KG, Harris TB, Havlik RS. Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: the Established Population for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996; 64:190-196.
8. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139:1180-1189.
9. Rimm EB, Stampfer MJ, Ascherio A, GioVannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-1456.
10. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328:1444-1449.
11. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3:194-202.
12. Todd S, Woodward M, Tunstall-Pedoe H, Smith CB. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-cause mortality: results from the Scottish Heart Health Study. Am J Epidemiol 1999; 150:1073-1080.
13. Heart Protection Study Collaborative Group. MRC/BHF. Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:23-33.
14. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 2001; 357:89-95.
15. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342:154-160.
16. GISSI-Prevenzione Investigators. Dietary supplements with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevention Trial. Lancet 1999; 354:447-455.
17. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study. J Natl Cancer Inst 1999; 91:2102-2106.
18. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET: the Beta-Carotene and Retinol Efficacy Trial. J Natl Canc Inst 1996; 88:1550-1559.
19. The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029-1035.
20. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334:1145-1149.
21. Cheug MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Atheroscler Thromb Vasc Biol 2001; 21:1320-1326.
22. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized, controlled trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant Study. Lancet 1996; 347:781-786.
23. Salonen JT, Nyyssonen K, Salonen R, Lakka HM, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000; 248:377-386.
24. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85:1483-1492.
25. Thurman J, Mooradian AD. Vitamin supplementation therapy in the elderly. Drugs Aging 1997; 11:433-449.
26. McLaren CJ, Bett JH, Nye JA, Halliday JW. Congestive cardiomyopathy and haemochromatosis: rapid progression possibly accelerated by excessive ingestion of ascorbic acid. Aust N Z J Med 1982; 12:187-188.
27. Melhus H, Michaelsson K, Kindmard A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 1998; 129:770-778.
28. Rothman KJ, Moore LL, Singer MR, Nguyen U-SDT, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med 1995; 333:1369-1373.
29. Berson EL, Rosner B, Sandberg MA, et al. Vitamin A supplementation for retinitis pigmentosa. Arch Ophthalmol 1993; 111:1456-1459.
30. Weber P, Bendich A, Machlin LJ. Vitamin E and human health: rationale for determining recommended intake levels. Nutrition 1997; 13:450-460.
31. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361:2017-2023.